ArticleOncotarget2016

Activated dendritic cells delivered in tissue compatible biomatrices induce in-situ anti-tumor CTL responses leading to tumor regression.

Vivek Verma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.